- A vaccine is a biological preparation which is administered to produce active acquired immunity for particular disease.
- Demand for vaccinations has increased over the last few years, due to the rising incidence of viral and bacterial infectious diseases.
- 1.5 million deaths could be avoided through enhanced global vaccination coverage.
The rising burden of several infectious and non-infectious diseases, an increasing government and non government support for vaccine development, and increasing research requests and current underdevelopment are likely to augment Global Vaccine Market growth.
A vaccine is a biological preparation which is administered to produce active acquired immunity for particular disease. It is prepared from weakened or killed forms of the microorganism such as bacteria & viruses or from its toxins or proteins. Administration of vaccines is called a “Vaccination”, which aids to increase the immune response against a specific pathogen.
The human body has a natural ability to learn about eliminating all sorts of germs or microbes that cause diseases. Vaccines leverage that ability. Usually vaccines are administered through injections, orally, or sprayed into the nose.
Vaccines can be divided into many types such as inactivated vaccines, attenuated vaccines, toxoid, and conjugate. Cholera, influenza, hepatitis A, polio, and rabies vaccines are inactivated vaccines.
The Global Vaccines Market report covers prominent players like Glaxo Smith Kline plc, Pfizer Inc., Merck & Co. Inc., Sanofi, CSL Limited, Emergent BioSolutions Inc. , Johnson & Johnson, Medimmune LLC, AstellasPharma Inc., Serum Institute of India, Bavarian Nordic, Mitsubishi Tanabe Pharma Corporation, Daiichi Sankyo Company Limited, Bavarian Nordic, Panacea Biotech, Protein Sciences
Corporation, AstraZeneca, Abbott, Bristol-Myers Squibb, Novavax Inc., Gritstone Oncology, PaxVax Corporation, Bharat Biotech, VBI Vaccines Inc., Dynavax Technologies Corporation, Immunomic Therapeutics Inc., Gamma Vaccines Pty Limited, Sinovac Biotech Ltd., Prokarium, ImmunoBiology Ltd., Janssen Pharmaceutical Company, Takeda Pharmaceuticals Company Ltd., Valeant Pharmaceuticals International Inc., China National Biotech, Tiantan, Hualan, Kangtai, Hissen and Jintan.
The Global Vaccines Market is categorized on the basis of the various diseases that can either be prevented or treated by using vaccines. Various diseases that are treated using H1N1 vaccines include influenza, meningococcal, cervical cancer, pneumococcal, hepatitis, measles, mumps, rubella, etc. Demand for vaccinations has increased over the last few years, due to the rising incidence of viral and bacterial infectious diseases.
Vaccinations are essentially administered to people of different age groups, which build up their immune system throughout their lifespan, giving protection against different types of infectious diseases. Vaccine technology is undergoing a revolution. A better understanding of the human immune system’s protective antibodies and cell-based responses to foreign antigens causes development of advanced diagnostics and improvement of therapeutic applications.
I Give You Masterclass Poker Course by Nick Petrangelo
Buy Research Report: Radiology Information Systems Market to Witness A Steep CAGR Of 8.3%
Buy Research Report: Mobile Water Treatment Systems Market Set to Grow US$ 1,952.0 Mn during 2020-2030
Buy Research Report: Electric Trolling Motors Market to Expand at a CAGR of 3.2% During 2020-2030
Buy Research Report: Global Solar Cells and Modules Market Strategic Assessment and Forecast by 2026
As further governments across the world identify the welfare of mass vaccination, the trend of vaccines providing healthcare solutions on a large scale will continue. Vaccines are a supreme tool for effective healthcare management due to their low cost and prolonged protection.
Several factors are driving market growth: increasing popularity of pediatric, travel, addiction and pediatric combination vaccines; newly developed vaccines that are safer and more effective; better public awareness; technological advancements in molecular genetics; and the adoption of novel vaccine delivery mechanisms. Moreover, the production of new therapeutic and prophylactic vaccines for fighting HIV/AIDS, congenital abnormalities, malaria and cancer, as well as other deadly diseases is also boosting Global Vaccine Market growth.
Immunization presently prevents an estimated 2 to 3 million deaths per year. Moreover an
additional 1.5 million deaths could be avoided through enhanced global vaccination coverage. Increasing acceptance of new and underused vaccines will highly strengthen its global usage in the upcoming future.
The Global Vaccines Market has been segmented on the basis of Technology, Indication, End User and Geography. On the basis of Technology, Global Vaccines Market is classified into Conjugate Vaccines, Live Attenuated Vaccines, Inactivated Vaccines Toxoid Vaccines, Recombinant Vaccines and Others. On the basis of Indication, Global Vaccines Market is segmented into Influenza, Pneumococcal Disease, Meningococcal Disease, Human Papilloma Virus, Rotavirus, Varicella, Diphtheria-Pertussis-Tetanus (DTP), Polio, Hepatitis, Measles-Mumps- Rubella (MMR) and others. On the basis of End User Global Vaccines Market is classified into Pediatric Vaccines, Adult Vaccines, Traveler Vaccines and Others.
The regions covered in Global Vaccines Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, Global Melanoma Drug Market is sub divided in to U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Global Vaccines Market Dynamics
A rise in incidence of infectious diseases such as influenza, malaria, pneumonia, measles, meningococcal meningitis, dengue, HIV, hepatitis, and diphtheria is somewhat high, as well as government initiatives for expanding vaccination coverage are likely to boost demand for vaccines globally. The ‘Pan-India campaign for contagious disease-Rubella Vaccination’ was launched in February 2017 to safeguard kids from chief childhood diseases like three-day measles and Measles. This nationwide vaccination campaign aims to administer measles-rubella vaccine (MR-VAC) to children between nine months and 15 years.
Increasing investments by companies are driving the vaccine market. Excessive costs related to storage and transportation of vaccines will restrain Global Vaccine Market growth. Limited reimbursement coverage and stringent government regulations for the approval of products will further hamper Global Vaccine Market expansion over the coming years. Crucial problems in the Global Vaccine Market now a days are product safety, supply shortages, use of vaccines to prevent infectious diseases and discoveries in vaccine delivery systems.